Vardeny, O., Claggett, B., Packer, M., Zile, M. R., Rouleau, J., Swedberg, K., … Solomon, S. D. (2016). Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial. European Journal of Heart Failure, 18(10), 1228–1234. https://doi.org/10.1002/ejhf.580

Vardeny, Orly, Brian Claggett, Milton Packer, Michael R. Zile, Jean Rouleau, Karl Swedberg, John R. Teerlink, et al. “Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial.” European Journal of Heart Failure 18, no. 10 (October 2016): 1228–34. https://doi.org/10.1002/ejhf.580.

Vardeny O, Claggett B, Packer M, Zile MR, Rouleau J, Swedberg K, et al. Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial. European Journal of Heart Failure. 2016 Oct;18(10):1228–34.

Vardeny, Orly, et al. “Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial.” European Journal of Heart Failure, vol. 18, no. 10, Oxford University Press (OUP), Oct. 2016, pp. 1228–34. Crossref, doi:10.1002/ejhf.580.

Vardeny O, Claggett B, Packer M, Zile MR, Rouleau J, Swedberg K, Teerlink JR, Desai AS, Lefkowitz M, Shi V, McMurray JJV, Solomon SD. Efficacy of sacubitril/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM‐HF trial. European Journal of Heart Failure. Oxford University Press (OUP); 2016 Oct;18(10):1228–1234.